Varney Shawn M, Bebarta Vikhyat S, Pitotti Rebecca L, Vargas Toni E
Wilford Hall Medical Center/Brooke Army Medical Center, San Antonio, TX, USA.
Pediatr Emerg Care. 2012 Sep;28(9):883-5. doi: 10.1097/PEC.0b013e3182676518.
In August 2007, the Food and Drug Administration (FDA) released a public health advisory recommending that over-the-counter cough and cold medications (CCMs) not be used in children younger than 2 years. Our objective was to assess parents' awareness and understanding of the guidelines.
We surveyed caregivers of children younger than 2 years in the emergency department of an urban tertiary care military hospital where civilian patients are also treated. After completing the survey, caregivers received a handout explaining the FDA's recommendations.
Our response rate was 99% (264/265). First-time parents constituted 45% (114/251) of responders. Education level was high school, 21%; some college, 36%; and college graduate, 40%. Thirty-one percent (77/247) were aware of the FDA guidelines. Of these 77, 44 (57%) reported the guidelines indicated CCMs were not safe in children younger than 2 years, and 18 (23%) said CCMs have caused death. Twenty-six percent (68/264) did not give CCMs to their children younger than 2 years, and 40% of these reported it was because of learning about the guidelines; 63% (165/264) reported CCMs were effective, 11% ineffective, and 27% did not know. Fifty-seven percent (151/263) reported CCMs were safe, 12% unsafe, and 31% unsure. Twenty-two percent (31/143) planned to use or continue to use CCMs in their children, 34% did not, 23% not sure, and 21% only if their doctor advised it.
The majority of caregivers were not aware of the FDA guidelines on CCM use in children younger than 2 years. Most thought CCMs were safe and effective.
2007年8月,美国食品药品监督管理局(FDA)发布了一项公共卫生咨询建议,即2岁以下儿童不应使用非处方止咳和感冒药(CCM)。我们的目的是评估家长对该指南的知晓度和理解情况。
我们对一家城市三级护理军队医院急诊科中2岁以下儿童的看护者进行了调查,该医院也收治 civilian 患者。完成调查后,看护者收到了一份解释FDA建议的资料。
我们的回复率为99%(264/265)。首次为人父母者占回复者的45%(114/251)。教育程度为高中的占21%;上过一些大学的占36%;大学毕业的占40%。31%(77/247)知晓FDA指南。在这77人中,44人(57%)报告指南表明CCM对2岁以下儿童不安全,18人(23%)表示CCM曾导致死亡。26%(68/264)不给2岁以下孩子使用CCM,其中40%报告是因为了解到该指南;63%(165/264)报告CCM有效,11%认为无效,27%表示不知道。57%(151/263)报告CCM安全,12%认为不安全,31%不确定。22%(31/143)计划在孩子身上使用或继续使用CCM,34%不打算用,23%不确定,21%仅在医生建议时使用。
大多数看护者不知道FDA关于2岁以下儿童使用CCM的指南。大多数人认为CCM安全且有效。